Madarnas Y - Search Results

1

Information needs of post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy.

Feldman-Stewart D, Madarnas Y, Mates M, Tong C, Grunfeld E, Verma S, Carolan H, Brundage M. Feldman-Stewart D, et al. Among authors: madarnas y. Patient Educ Couns. 2013 Oct;93(1):114-21. doi: 10.1016/j.pec.2013.03.019. Epub 2013 Jun 6. Patient Educ Couns. 2013. PMID: 23747087

2

Breast cancer in pregnancy: a literature review.

Molckovsky A, Madarnas Y. Molckovsky A, et al. Among authors: madarnas y. Breast Cancer Res Treat. 2008 Apr;108(3):333-8. doi: 10.1007/s10549-007-9616-6. Epub 2007 May 26. Breast Cancer Res Treat. 2008. PMID: 17530426 Review.

3

Adjuvant/neoadjuvant trastuzumab therapy in women with HER-2/neu-overexpressing breast cancer: a systematic review.

Madarnas Y, Trudeau M, Franek JA, McCready D, Pritchard KI, Messersmith H. Madarnas Y, et al. Cancer Treat Rev. 2008 Oct;34(6):539-57. doi: 10.1016/j.ctrv.2008.03.013. Epub 2008 May 27. Cancer Treat Rev. 2008. PMID: 18502589 Review.

4

An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor-positive early breast cancer.

Verma S, Sehdev S, Joy A, Madarnas Y, Younus J, Roy JA. Verma S, et al. Among authors: madarnas y. Curr Oncol. 2009 Jul;16 Suppl 2(Suppl 2):S1-13. doi: 10.3747/co.v16i0.455. Curr Oncol. 2009. PMID: 19672416 Free PMC article.

5

Models of care for early-stage breast cancer in Canada.

Madarnas Y, Joy AA, Verma S, Sehdev S, Lam W, Sideris L. Madarnas Y, et al. Curr Oncol. 2011 May;18 Suppl 1(Suppl 1):S10-9. doi: 10.3747/co.v18i0.898. Curr Oncol. 2011. PMID: 21698058 Free PMC article.

6

Patient adherence to aromatase inhibitor treatment in the adjuvant setting.

Verma S, Madarnas Y, Sehdev S, Martin G, Bajcar J. Verma S, et al. Among authors: madarnas y. Curr Oncol. 2011 May;18 Suppl 1(Suppl 1):S3-9. doi: 10.3747/co.v18i0.899. Curr Oncol. 2011. PMID: 21698059 Free PMC article.

7

Information for decision making by post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy.

Feldman-Stewart D, Madarnas Y, Mates M, Tong C, Grunfeld E, Verma S, Carolan H, Brundage M. Feldman-Stewart D, et al. Among authors: madarnas y. Breast. 2013 Oct;22(5):919-25. doi: 10.1016/j.breast.2013.04.020. Epub 2013 May 28. Breast. 2013. PMID: 23721853

8

Locoregional therapy of locally advanced breast cancer: a clinical practice guideline.

Brackstone M, Fletcher GG, Dayes IS, Madarnas Y, SenGupta SK, Verma S; Members of the Breast Cancer Disease Site Group. Brackstone M, et al. Among authors: madarnas y. Curr Oncol. 2015 Mar;22(Suppl 1):S54-66. doi: 10.3747/co.22.2316. Curr Oncol. 2015. PMID: 25848339 Free PMC article.

9

Are medical oncologists biased in their treatment of the large woman with breast cancer?

Madarnas Y, Sawka CA, Franssen E, Bjarnason GA. Madarnas Y, et al. Breast Cancer Res Treat. 2001 Mar;66(2):123-33. doi: 10.1023/a:1010635328299. Breast Cancer Res Treat. 2001. PMID: 11437098

10

Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: a systematic review.

Flemming J, Madarnas Y, Franek JA. Flemming J, et al. Among authors: madarnas y. Breast Cancer Res Treat. 2009 May;115(2):255-68. doi: 10.1007/s10549-008-0137-8. Epub 2008 Aug 6. Breast Cancer Res Treat. 2009. PMID: 18683044 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters